Eisai Co Ltd (ESAIY)
9.95
-0.06
(-0.60%)
USD |
OTCM |
Apr 26, 16:00
Eisai Gross Profit (Quarterly): 998.97M for Dec. 31, 2022
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 998.97M |
September 30, 2022 | 935.49M |
June 30, 2022 | 1.056B |
March 31, 2022 | 1.207B |
December 31, 2021 | 1.396B |
September 30, 2021 | 1.116B |
June 30, 2021 | 1.458B |
March 31, 2021 | 1.005B |
December 31, 2020 | 1.349B |
September 30, 2020 | 1.037B |
June 30, 2020 | 1.183B |
March 31, 2020 | 1.479B |
December 31, 2019 | 1.313B |
September 30, 2019 | 978.65M |
June 30, 2019 | 1.011B |
March 31, 2019 | 1.206B |
December 31, 2018 | 952.79M |
September 30, 2018 | 1.012B |
June 30, 2018 | 965.04M |
March 31, 2018 | 1.061B |
December 31, 2017 | 892.77M |
September 30, 2017 | 815.58M |
June 30, 2017 | 832.15M |
March 31, 2017 | 719.70M |
December 31, 2016 | 821.53M |
Date | Value |
---|---|
September 30, 2016 | 826.50M |
June 30, 2016 | 806.56M |
March 31, 2016 | 662.20M |
December 31, 2015 | 832.70M |
September 30, 2015 | 705.31M |
June 30, 2015 | 740.62M |
March 31, 2015 | 750.97M |
December 31, 2014 | 788.27M |
September 30, 2014 | 871.17M |
June 30, 2014 | 829.11M |
March 31, 2014 | 1.042B |
December 31, 2013 | 861.45M |
September 30, 2013 | 1.057B |
June 30, 2013 | 1.080B |
March 31, 2013 | 1.044B |
December 31, 2012 | 1.231B |
September 30, 2012 | 1.269B |
June 30, 2012 | 1.294B |
March 31, 2012 | 1.251B |
December 31, 2011 | 1.682B |
September 30, 2011 | 1.557B |
June 30, 2011 | 1.524B |
March 31, 2011 | 1.393B |
December 31, 2010 | 1.917B |
September 30, 2010 | 1.946B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
935.49M
Minimum
Sep 2022
1.479B
Maximum
Mar 2020
1.168B
Average
1.116B
Median
Sep 2021
Gross Profit (Quarterly) Benchmarks
Biogen Inc | 1.748B |
Daiichi Sankyo Co Ltd | 2.182B |
Takeda Pharmaceutical Co Ltd | 4.956B |
Nxera Pharma Co Ltd | 37.53M |
PeptiDream Inc | 20.24M |